CYDY Company Profile

CYDY Time & Sales

CYDY Recent News

CYDY Filings

CYDY Financials

CYDY Buy Rating

Figgs

07/09/2025 3:27:25 PM

Leronlimab was studied in combination (4)

sean007

07/09/2025 3:13:43 PM

Merck to buy Verona in deal worth (3)

Figgs

07/09/2025 2:22:50 PM

Leronlimab, a humanized monoclonal (2)

brentie

07/09/2025 11:56:21 AM

This is from stocktwits. Nothing too (12)

KenChowder

07/09/2025 7:57:12 AM

You forgot the antecedent: Are you (23)

Mr3Putt

07/09/2025 7:51:47 AM

Youve got to ask yourself one (5)

chazzledazzle

07/08/2025 11:38:42 PM

I feel you. But Im strong. And a (7)

cardamine

07/08/2025 11:19:50 PM

thanks, brentie -- LL's the only CCR5 (2)

mountaineer

07/08/2025 5:50:34 PM

Yes the following is AI generated, but (8)

brentie

07/08/2025 4:16:26 PM

"Finally, the Leronlimab, Ulocuplumab, (24)

Camp2800

07/08/2025 12:28:00 PM

When you add up all of the tea leaves (11)

Riztheinvestor

07/08/2025 10:25:20 AM

When the FDA completely lost oversight (7)

grow

07/08/2025 10:24:32 AM

Yes I agree. Not seeing the ESMO CRC (3)

Respert24

07/08/2025 10:15:34 AM

Exactly. You'd hope everyone involved (13)

Riztheinvestor

07/08/2025 10:12:45 AM

Great pasta metaphor. But some of us (3)

Jake2212

07/08/2025 10:03:46 AM

Respert: And when the FDA stopped LL (12)

Riztheinvestor

07/08/2025 10:00:14 AM

This is very interesting. Havent (8)

mountaineer

07/08/2025 9:30:46 AM

Good job! Only 376 words (8)

Respert24

07/08/2025 8:55:40 AM

Your questions simple enough without (27)

MGK_2

07/08/2025 7:10:13 AM

I didn't get any responses, so I put (8)

ohm20

07/08/2025 12:50:27 AM

So I turned to our " friend" A I for (9)

Shelly2626

07/07/2025 11:48:08 PM

Been here , but in CYDY SINCE (5)

brentie

07/07/2025 10:43:59 PM

Leronlimab Shows Encouraging Survival (10)

brentie

07/07/2025 10:28:32 PM

New Trials Target Brain, Bladder, (7)

My69z

07/07/2025 8:37:28 PM

The FDA ..HAS approved LL @ 700mg CRC (7)

MidnightRider

07/07/2025 8:07:57 PM

It's obvious I have been struggling (9)

Mr3Putt

07/07/2025 6:21:49 PM

FWIW on July 9 it'll be the one year (5)

Shelly2626

07/07/2025 6:18:55 PM

GLTA Longs..... I'm extremely (10)

chazzledazzle

07/07/2025 5:52:26 PM

Short term newsmakers are Company (6)

ohm20

07/07/2025 5:50:56 PM

Short version: if a company licenses (9)

Riztheinvestor

07/07/2025 5:47:18 PM

If I had to guess, and Im not (17)

KenChowder

07/07/2025 5:18:10 PM

Yes, up nearly 12% on the day -- (6)

hoops

07/07/2025 3:48:32 PM

In the meantime CYDY is quietly up 12% (4)

nelsonsjavaheads

07/07/2025 3:23:32 PM

Just RELAX. This is a board that we are (16)

My69z

07/07/2025 2:48:42 PM

Like i said....he was talking 2 someone

cardamine

07/07/2025 2:44:46 PM

poster display session in Hall B0 on

Evil Rabbit

07/07/2025 2:44:31 PM

Because he said he had you on ignore?? (9)

Evil Rabbit

07/07/2025 2:41:27 PM

Language like that will get you blanket (4)

HouseofCards

07/07/2025 1:27:13 PM

I would expect updates on any or all of (4)

KenChowder

07/07/2025 12:43:08 PM

Short version: if a company licenses (1)

Cycl2R

07/07/2025 11:32:45 AM

Jake wrote re LL TNBC conclusive trial: (3)

MidnightRider

07/07/2025 11:08:42 AM

Can someone please offer an opinion (1)

Respert24

07/07/2025 10:51:39 AM

I cant see the business model (21)

Mr3Putt

07/07/2025 10:31:49 AM

Not a pharma rep nor exec so I have no

Evil Rabbit

07/07/2025 10:30:37 AM

The five-year anniversary of our RTF (14)

My69z

07/07/2025 10:25:16 AM

Or, what do you think about ICI's

My69z

07/07/2025 10:12:07 AM

Cytodyn's not for sale ---- for yrs (1)

Mr3Putt

07/07/2025 10:05:14 AM

Paying Cytodyn dosen't get them ICI

My69z

07/07/2025 9:59:29 AM

Partnering directly with us, dosen't (1)

Mr3Putt

07/07/2025 9:46:29 AM

If LL makes all ICI's better, why (4)

Newer

Older

Recent Articles

• Cepton, Inc. Faces Class Action for Alleged Securities Fraud
• Strategic Acquisition: Hawkeye Harley-Davidson Joins Junge Group
• STRADVISION Aims for KOSDAQ Listing to Boost Tech Presence
• Mandala Capital Expands Food Systems Resilience with GCF Approval
• Exploring the Future of Post-Quantum Cryptography Industry
• Revolutionizing Manufacturing: The Role of AI in MES
• The Incredible Investment Journey of Palo Alto Networks Over 10 Years
• Newmark Secures Major $600 Million Financing for Multifamily Growth
• Network Media Group Reports Strong Third Quarter Performance
• Uber Launches in Barbados, Enhancing Travel Experience on Island
• Uber Introduces Convenient Rides for Tourists in Barbados
• Newmark Secures $600 Million in Multifamily Financing Deal
• National Initiative Offers Free Internet to SNAP Recipients
• Micron Technology to Share Insights at Upcoming Investor Event
• MediciNova's Groundbreaking Strategy for Atherosclerosis Treatment
• Mobix Labs Secures 180-Day Period to Meet Nasdaq Compliance
• Micron Technology's Upcoming Conference Participation Update
• An Insight into Vertex Pharmaceuticals' Growth Over 15 Years
• Key Information for Fortinet Investors Ahead of Legal Deadlines
• Cephia Raises $4M for Groundbreaking Metasurface Technology
• The Lemon Pros Introduces Handy Tool for Car Recall Checks
• Saudi Arabia's Shift: Embracing New Economic Paradigm
• Black Diamond Group Exceeds Revenue Expectations in Q3 2025
• Exploring the Impressive Long-term Growth of IES Holdings
• Amazon's Q3 2025 Earnings Highlights: Strong Revenue and Innovations
• Black Diamond Group Achieves Impressive Q3 Growth with Dividend Increase
• ANSI Advances Electric Vehicle Standards with Progress Report
• Rosewood Hong Kong Crowned Best Hotel in Worldwide Ranking
• Understanding Your Rights in the aTyr Pharma Securities Case
• Bright Minds Biosciences to Share Innovations at Key Conferences
• Voyageur and Evolve Reveal Positive Shareholder Voting Results
• Bright Minds Biosciences Set for Key Conferences Ahead
• EchoStar's Impressive Stock Growth: A 5-Year Review
• Atlassian's Strong Q1 Results Show AI Driving Growth
• Innovative Partnership to Revolutionize Oil Recovery Technology
• Recognition for Coach Hassell: Celebrating His National Achievement
• Dr. Antoanella Calame Earns Prestigious Doctor Recognition
• ThreeD Capital Inc. Strengthens Investor Connections for Growth
• The Growth of a $1000 Investment in Simon Property Group Shares
• Experience Tailored Confidence This Black Friday with INDOCHINO
• Celebrating Three Decades of Outstanding Hospitality
• BridgeBio Oncology's Latest Advances at the SABCS Event
• Transforming a $100 Investment in Salesforce into Wealth Over Time
• Streamex Corp. Secures Continued Nasdaq Listing Approval News
• Intuitive Machines Secures Funding for Space Nuclear Power
• Revolutionizing Digital Assets: The Power of FLAMGP AI
• Millicom's Strategic Acquisition of Telefónica in Ecuador
• RCI Hospitality Holdings Faces Class Action Amid Allegations
• Investing in MSCI: A Journey Over 15 Years Explained
• Fluor Corporation Investors: Essential Class Action Insights